Please use this identifier to cite or link to this item: https://doi.org/10.3389/fneur.2020.604688
DC FieldValue
dc.titleImpact of Cryotherapy on Sensory, Motor, and Autonomic Neuropathy in Breast Cancer Patients Receiving Paclitaxel: A Randomized, Controlled Trial
dc.contributor.authorNg, D.Q.
dc.contributor.authorTan, C.J.
dc.contributor.authorSoh, B.C.
dc.contributor.authorTan, M.M.L.
dc.contributor.authorLoh, S.Y.
dc.contributor.authorTan, Y.E.
dc.contributor.authorOng, H.H.
dc.contributor.authorTeng, P.P.C.
dc.contributor.authorChan, J.J.
dc.contributor.authorChay, W.Y.
dc.contributor.authorLee, J.
dc.contributor.authorLai, G.
dc.contributor.authorBeh, S.Y.
dc.contributor.authorTan, T.J.Y.
dc.contributor.authorYap, Y.S.
dc.contributor.authorLee, G.E.
dc.contributor.authorWong, M.
dc.contributor.authorDent, R.
dc.contributor.authorLo, Y.L.
dc.contributor.authorChan, A.
dc.contributor.authorLoh, K.W.-J.
dc.date.accessioned2021-08-10T03:08:50Z
dc.date.available2021-08-10T03:08:50Z
dc.date.issued2020
dc.identifier.citationNg, D.Q., Tan, C.J., Soh, B.C., Tan, M.M.L., Loh, S.Y., Tan, Y.E., Ong, H.H., Teng, P.P.C., Chan, J.J., Chay, W.Y., Lee, J., Lai, G., Beh, S.Y., Tan, T.J.Y., Yap, Y.S., Lee, G.E., Wong, M., Dent, R., Lo, Y.L., Chan, A., Loh, K.W.-J. (2020). Impact of Cryotherapy on Sensory, Motor, and Autonomic Neuropathy in Breast Cancer Patients Receiving Paclitaxel: A Randomized, Controlled Trial. Frontiers in Neurology 11 : 604688. ScholarBank@NUS Repository. https://doi.org/10.3389/fneur.2020.604688
dc.identifier.issn1664-2295
dc.identifier.urihttps://scholarbank.nus.edu.sg/handle/10635/196269
dc.description.abstractIntroduction: We conducted a randomized controlled trial evaluating the efficacy and tolerability of cryotherapy in preventing chemotherapy-induced peripheral neuropathy (CIPN) in patients with early breast cancer receiving neo/adjuvant weekly paclitaxel. Methods: Patients were recruited from the National Cancer Centre Singapore and randomized (1:1) to receive either cryotherapy or usual care. Cryotherapy was applied as frozen gloves and socks on all extremities from 15 min before paclitaxel until 15 min post-infusion every cycle. Efficacy was measured by patient-reported outcomes (Patient Neurotoxicity Questionnaire [PNQ] and EORTC QLQ-CIPN20) and electrophysiological assessments. The primary endpoint was PNQ severity at 2 weeks after 12 cycles of weekly paclitaxel. Results: A total of 46 patients were recruited, of which 8 dropped out before paclitaxel treatment, leaving 38 evaluable. There was no significant difference in PNQ severity between cryotherapy and usual care at 2 weeks after paclitaxel treatment (sensory: p = 0.721; motor: p = 1.000). A benefit was observed at 3 months post-paclitaxel based on PNQ (sensory: 14.3 vs. 41.2%, p = 0.078; motor: 0 vs. 29.4%, p = 0.012) and CIPN20 (sensory: ? = ?3.6, 95%CI = ?10.5–3.4, p = 0.308; motor: ? = ?7.3, 95%CI = ?14.6–0, p = 0.051). Additionally, cryotherapy subjects have lower CIPN20 autonomic score (? = ?5.84, 95%CI = ?11.15 to ?0.524, p = 0.031) and higher sympathetic skin response hand amplitudes (? = 0.544, 95%CI = 0.108–0.98, p = 0.014), suggesting possible autonomic benefits from cryotherapy. Temporary interruption with cryotherapy occurred in 80.9% of the subjects due to cold intolerance. Conclusions: There is insufficient evidence that cryotherapy prevents sensory neuropathy which may be due to the high rates of cryotherapy interruption in this study. The autonomic benefits of cryotherapy should be further investigated with appropriate outcome measures. Clinical Trial Registration: ClinicalTrials.gov: NCT03429972. © Copyright © 2020 Ng, Tan, Soh, Tan, Loh, Tan, Ong, Teng, Chan, Chay, Lee, Lai, Beh, Tan, Yap, Lee, Wong, Dent, Lo, Chan and Loh.
dc.publisherFrontiers Media S.A.
dc.rightsAttribution 4.0 International
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/
dc.sourceScopus OA2020
dc.subjectbreast cancer
dc.subjectchemotherapy-induced peripheral neuropathy
dc.subjectcryotherapy
dc.subjectelectrophysiological assessment
dc.subjectpaclitaxel
dc.subjectpatient-reported outcome
dc.typeArticle
dc.contributor.departmentPHARMACY
dc.description.doi10.3389/fneur.2020.604688
dc.description.sourcetitleFrontiers in Neurology
dc.description.volume11
dc.description.page604688
Appears in Collections:Elements
Staff Publications

Show simple item record
Files in This Item:
File Description SizeFormatAccess SettingsVersion 
10_3389_fneur_2020_604688.pdf1.89 MBAdobe PDF

OPEN

NoneView/Download

Google ScholarTM

Check

Altmetric


This item is licensed under a Creative Commons License Creative Commons